CTOs on the Move


 
As the intraoperative imaging expert, IMRIS, Deerfield Imaging measurably improves patient outcomes through planning, product integration and clinical workflow to give surgeons access to diagnostic quality scans in operating room suites. The IMRIS Surgical Theatre, which uniquely transport MR and CT scanners to the patient using ceiling-mounted rails and incorporate other IMRIS imaging technology, are sold globally to hospitals that deliver clinical services to patients in neurosurgical, spinal, interventional and orthopedic markets.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.imris.com
  • 5101 Shady Oak Rd
    Minnetonka, MN USA 55343
  • Phone: 763.203.6300

Executives

Name Title Contact Details

Similar Companies

Oasis Lifestyle

Oasis Manufactures whirlpools, soaking tubs and shower stalls. We have been in business for over twenty years. At Oasis we strive to ensure quality and value in our whirlpool baths and systems. We study the current trends and market needs to stay at the

Bios International Corp

Bios International Corp is a Butler, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardinal Health

Cardinal Health, Inc. (NYSE: CAH), a global health services and products company, brings scaled solutions that help our customers thrive in a changing world. We improve the cost-effectiveness of healthcare through solutions that improve the efficiency of the supply chain; optimize the process and performance of healthcare; provide clinically proven, daily use medical products and pharmaceuticals; and connect patients, providers, payers, pharmacists and manufacturers for seamless care coordination and better patient management. Backed by nearly 100 years of experience, we rank among the top 50 on the Fortune 500 and among the Fortune Global 100. We support our partners with more than 37,000 employees in nearly 60 countries worldwide.

Progressive Medical International

Progressive Medical International is a Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LuxCath

LuxCath is the leader in using fluorescence and optics to directly view lesions during cardiac ablation procedures. The company`s breakthrough technology offers the potential for dramatic evolution in the way ablation procedures are performed by assessing tissue contact and enabling direct lesion progression monitoring. LuxCath`s patented solution aims to ensure the quality of catheter lesions at the moment they are made. LuxCath enables constant optical tissue contact assessment and provides valuable lesion formation and progression information during each ablation.